Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

Also called NCT07069738

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07069738
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07069738. Randomized; single masking; primary purpose treatment. Start 2025-10-22 (actual); primary completion 2029-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Acronym
SYNCHRONICITY
Condition
Heart Failure - NYHA II - IV
Intervention (Device)
CRT-D with a Quadripolar LV lead
Intervention (Device)
CRT-D with INGEVITY+ pace/sense lead
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct07069738
Content hash
7d70d4adb4ff503862f8bebe84831eadae39c7284f52c5f4df446de2230e9b79